Biomarkers are emerging as a potential tool for screening or diagnosing sarcopenia. We
aimed to summarize the current evidence on the diagnostic test accuracy of biomarkers for …

Objective Sarcopenia is a syndrome of decreased muscle mass and deficits in muscle
strength and physical function. We aimed to investigate the relationship between …

Background: It is well known that sarcopenia is a common risk factor in patients with
gastrointestinal tumours, which may negatively affect the clinical outcome and prognosis …

Background Lung function decline is associated with sarcopenia, known as loss of skeletal
muscle mass. The serum creatinine to cystatin C ratio (CCR) has been proposed as a …

Purpose Low serum creatinine/cystatin C ratio (CCR) is associated with unfavorable
characteristics in patients with chronic obstructive pulmonary disease (COPD); however, the …

Background Several creatinine-and cystatin-C–based indices have been proposed as
sarcopenia predictors. This study aimed to compare serum creatinine-and cystatin-C–based …

Introduction Low creatinine to cystatin-C ratio (Cr/Cys-C) may be a biomarker for low-muscle
mass. Furthermore, low Cr/Cys-C is associated with decreased overall survival (OS), but to …

Background Sarcopenia is reported to be associated with depression. Recently, serum
creatinine to cystatin C ratio (CCR) has been recommended as a promising biomarker for …

The purpose of this study was to investigate the relationship between the sarcopenia index
(SI) and stroke risk in elderly patients with hypertension. This study included 5145 stroke …

Background Sarcopenia is an important prognostic factor, but its optimal screening methods
remain challenging. Several new indices developed based on serum creatinine (Cr) and …